Cliniphar (TSE:432A) FCF Margin %: 7.25% (As of Mar. 2026) — 393% Above Median


TSE:432A Cliniphar Ltd TSE:432A
20 GF Score
Price 円1,450.00
! 3 Warning Signs
View Full Analysis

What is Cliniphar FCF Margin %?

Cliniphar TSE:432A 20 FCF Margin % is 7.25% as of Mar. 2026, which is 393% above its 10-year median of 1.47. GuruFocus rates TSE:432A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cliniphar's Free Cash Flow for the six months ended in Mar. 2026 was 円268 Mil. Cliniphar's Revenue for the six months ended in Mar. 2026 was 円3,701 Mil. Therefore, Cliniphar's FCF Margin % for the quarter that ended in Mar. 2026 was 7.25%.

As of today, Cliniphar's current FCF Yield % is 18.50%.

The historical rank and industry rank for Cliniphar's FCF Margin % or its related term are showing as below:

TSE:432A' s FCF Margin % Range Over the Past 10 Years
Min: 1.33   Med: 1.47   Max: 7.25
Current: 7.25


During the past 3 years, the highest FCF Margin % of Cliniphar was 7.25%. The lowest was 1.33%. And the median was 1.47%.

TSE:432A's FCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.1 vs TSE:432A: 7.25


Cliniphar FCF Margin % Related Terms


Cliniphar FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cliniphar's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cliniphar FCF Margin % Chart

Cliniphar Annual Data
Trend Mar24 Mar25 Mar26
FCF Margin %
1.33 1.47 7.25

Cliniphar Semi-Annual Data
Mar24 Mar25 Mar26
FCF Margin % 1.33 1.47 7.25

Cliniphar FCF Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Cliniphar's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cliniphar FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cliniphar's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cliniphar's FCF Margin % falls into.


TSE:432A
20GF Score
Cliniphar Ltd TSE:432A
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cliniphar FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cliniphar's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=268.292/3700.714
=7.25 %

Cliniphar's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=268.292/3700.714
=7.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 7.25% mean?
Cliniphar (TSE:432A) has a FCF Margin % of 7.25% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cliniphar and its competitors. This is 393% above median its historical median of 1.47. Over the past decade, Cliniphar's FCF Margin % has ranged from 1.33 to 7.25.
Is Cliniphar's FCF Margin % too high?
Cliniphar's current FCF Margin % of 7.25% is 393% above median its 10-year median of 1.47. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 7.25. The Healthcare Providers & Services industry median FCF Margin % is 3.10. Cliniphar's value of 7.25% is 133.9% above this industry median. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's FCF Margin % compare to competitors?
Cliniphar's FCF Margin % of 7.25% can be compared against companies in the Healthcare Providers & Services industry. The industry median FCF Margin % is 3.10. Cliniphar's value of 7.25% is 133.9% above this benchmark. Historically, Cliniphar's own FCF Margin % has ranged from 1.33 to 7.25 over the past decade. While the company's 10-year median is 1.47 vs. the industry median of 3.10, Cliniphar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cliniphar's current FCF Margin % of 7.25% is 133.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cliniphar and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cliniphar's current FCF Margin % is 7.25%, which is 393% above median its own 10-year median of 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current FCF Margin % of 7.25%. The current FCF Margin % is 7.25%, which is 393% above median its 10-year median of 1.47 and 133.9% above the Healthcare Providers & Services industry median of 3.10. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current FCF Margin % is 7.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cliniphar Business Description

Address 1-7-31, Otemae, 5th Floor, OMM Building, Otemae, Chuo-ku, Osaka-shi, Osaka, JPN, 540-0008
Cliniphar Ltd is engaged in Pharmaceutical Wholesale and Distribution Business for Domestic and International Markets.
20GF Score

Get the complete analysis for TSE:432A

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,450.00
Price